Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-12 · accession 0001209191-22-024228 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-12 | 2022-04-12 | CCCC | Fisher Stewart | CSO | M - OptEx | $4.88 | +28.1K | 45.5K | +162% | +$137.1K |
| DM | 2022-04-12 | 2022-04-12 | CCCC | Fisher Stewart | CSO | M - OptEx | $0.00 | -28.1K | 35.6K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-12 | M | A | 25,928 | $4.98 | 71,390 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-12 | M | A | 2,156 | $3.71 | 45,462 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-04-12 | M | D | 25,928 | $0.00 | 48,152 | D | $4.98 · — to 2030-07-08 | 25,928 Common Stock | (F2) This option vests and becomes exercisable in 20 equal quarterly installments, with the first installment vested on September 5, 2020. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-04-12 | M | D | 2,156 | $0.00 | 35,572 | D | $3.71 · — to 2028-04-23 | 2,156 Common Stock | (F1) 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter. |